Pag-aaral pangklinika para sa Trangkaso sa California
14 pag-aaral para sa Trangkaso ang naghahanap ng mga kalahok sa mga site sa California.
Mga Lungsod sa California
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)
- Profound Research LLC ( Site 0743), Carlsbad
- Triallogix Medical Corporation ( Site 0615), Fullerton
- Paradigm Clinical Research, LLC ( Site 0733), Modesto
- at 4 pa
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07159763A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Children
- Paradigm Clinical Research Centers, LLC, Modesto
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 9 hanggang 17 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07870330A Trial to Evaluate the Effect of CD388/MK1406 on the Immunogenicity of Fluzone® HD Vaccine (CD388.SQ.1.08/MK-1406-007)
- Parexel ( Site 0001), Glendale
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 49 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07300085Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Fresno
- Research Site, Newport Beach
- Research Site, Torrance
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT05624450High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients
- Stanford University, Stanford
Nagre-recruitPhase 2
Edad 3 hanggang 17 · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT05947071A Study to Evaluate the Immune Response and Safety of a Vaccine Against Influenza in Adults 18-64 Years of Age
- GSK Investigational Site, San Diego
Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 64 · Lahat ng kasarian · Na-update Okt 9, 2026 · NCT07851246A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
- GSK Investigational Site, Dublin
- GSK Investigational Site, Escondido
- GSK Investigational Site, Fair Oaks
- at 7 pa
Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
Edad 65 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07805707Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
- Peninsula Research Associates- Site Number : 8400011, Rolling Hills Estates
- California Research Foundation- Site Number : 8400007, San Diego
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07779408Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years
- Kaiser Permanente Northern California (entire region), Oakland
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 65 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT06029933The Effects of Endotracheal Suctioning on Pain and Serum Markers
- Loma Linda University Medical Center Troesh Medical Campus, Loma Linda
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT06692400A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
- GSK Investigational Site, Fair Oaks
- GSK Investigational Site, San Diego
Nagre-recruitPhase 1
Edad 65 hanggang 85 · Lahat ng kasarian · Na-update Hun 30, 2026 · NCT07464314A Study to Learn About mRNA Vaccines Against Influenza in Adults
- Diablo Clinical Research, LLC d/b/a Flourish Research, Walnut Creek
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT07431853Understanding Immunity to the Flu Vaccine in COVID-19 Patients
- Stanford University, Palo Alto
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 9 hanggang 64 · Lahat ng kasarian · Na-update Mar 18, 2026 · NCT04579588Immune Defense Protein Impact On Respiratory Immune Outcomes
- People Science, Inc., Los Angeles
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 60 pataas · Lahat ng kasarian · Na-update Mar 12, 2026 · NCT07431840Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.